SEC Form 4 · accession 0001144204-18-000868
CAPRICOR THERAPEUTICS, INC. · CAPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rachel Smith
Officer — Vice President of R&D
Period of report
Dec 22, 2017
Accepted (ET)
Jan 4, 2018 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 22, 2017 | M | 20,748 | $0.16 | A | 20,748 | D | |
| Common StockF2 | Dec 22, 2017 | F | 2,244 | $1.48 | D | 18,504 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.16 | Dec 22, 2017 | M | 20,748 | D | Jan 1, 2008 | Jan 1, 2018 | Common Stock | 20,748 | 0 | D |
Explanation of responses
- F1On December 22, 2017, the Reporting Person exercised, via cashless exercise, stock options for 20,748 shares of Common Stock. The exercise price was $0.16 per share and the exercise was subject to the terms and conditions of a Stock Option Award which was granted on January 1, 2008 under the Company's 2006 Stock Option Plan.
- F2Reflects 2,244 shares withheld by the Issuer at the market price of $1.48 per share to fund the cashless exercise of 20,748 options.